Open access · CC-BY
via OpenAlex
Intersection of Polycystic Ovary Syndrome and the Gut Microbiome
Maryan Rizk, Varykina G. Thackray
Journal of the Endocrine Society · 2020 · ▲ 106 citations
Abstract
The etiology of polycystic ovary syndrome (PCOS) remains unclear, although studies indicate that both genetic and environmental factors contribute to the syndrome. In 2012, Tremellen and Pearce proposed the idea that dysbiosis of the intestinal (gut) microbiome is a causative factor of metabolic and reproductive manifestations of PCOS. In the past 5 years, studies in both humans and rodent models have demonstrated that changes in the taxonomic composition of gut bacteria are associated with PCOS. Studies have also clearly shown that these changes in gut microbiota are associated with PCOS as opposed to obesity, since these changes are observed in women with PCOS that are both of a normal weight or obese, as well as in adolescent girls with PCOS and obesity compared with body mass index- and age-matched females without the disorder. Additionally, studies in both women with PCOS and rodent models of PCOS demonstrated that hyperandrogenism is associated with gut microbial dysbiosis, indicating that androgens may modulate the gut microbial community in females. One study reported that the fecal microbiome transplantation of stool from women with PCOS or exposure to certain bacteria resulted in a PCOS-like phenotype in mice, while other studies showed that exposure to a healthy gut microbiome, pre/probiotics, or specific gut metabolites resulted in protection from developing PCOS-like traits in mice. Altogether, these results suggest that dysbiosis of the gut microbiome may be sufficient to develop PCOS-like symptoms and that modulation of the gut microbiome may be a potential therapeutic target for PCOS.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1210/jendso/bvaa177
- Canonical
- link ↗
- Fetched
- 2026-09-12 MST
Cite this
APA
Rizk, M., & Thackray, V.G. (2020). Intersection of Polycystic Ovary Syndrome and the Gut Microbiome. <em>Journal of the Endocrine Society</em>. https://doi.org/10.1210/jendso/bvaa177
Vancouver
Rizk M, Thackray VG. Intersection of Polycystic Ovary Syndrome and the Gut Microbiome. Journal of the Endocrine Society. 2020. doi:10.1210/jendso/bvaa177.
BibTeX
@article{maryan2020Inters,
title = {Intersection of Polycystic Ovary Syndrome and the Gut Microbiome},
author = {Maryan Rizk and Varykina G. Thackray},
journal = {Journal of the Endocrine Society},
year = {2020},
doi = {10.1210/jendso/bvaa177},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Experientia supplementum 2018
Citation only
Microbiome and Gut Dysbiosis
mBio 2013
Open access · CC-BY
The Gut Microbiome Modulates Colon Tumorigenesis
University Hospital, Clermont-Ferrand 2018
Open access · US-GOV
Predictive Value of Innovative Prognostic Markers (Gut Microbiota, Sarcopenia, Metabolic Syndrome and Obesity) on Surgical and Oncologic Results in the Management of Sporadic Colorectal Adenocarcinoma.
International Journal of Molecular Sciences 2022
Open access · CC-BY
Gut Microbiome Changes in Gestational Diabetes
Frontiers in Nutrition 2019
Open access · CC-BY
Dietary and Gut Microbiota Polyamines in Obesity- and Age-Related Diseases
Research Square 2020
Preprint · CC-BY